Influence of particle size and material properties on mucociliary clearance from the airways

Andreas Henning, Marc Schneider, Noha Nafee, Leon Muijs, Erik Rytting, Xiaoying Wang, Thomas Kissel, Dirk Grafahrend, Doris Klee, Claus Michael Lehr

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Mucociliary clearance (MC), designed by evolution to eliminate inhaled and possibly noxious material from the airways, considerably limits the benefit of inhalation therapy. Although the principles of MC seem to be understood, there are still many open questions on mucociliary particle clearance. In this study a trachea-based in vitro model was used to investigate the effect of particle size, zeta-potential, and mucoadhesive particle properties on mucociliary particle clearance. As different sized particles (50-6000 nm) were tested at equal mass concentrations, size related factors, namely particle number and particle surface area, varied by several orders of magnitude between the experiments. Surprisingly, particle clearance for 50 nm up to 6000 nm-sized polystyrene particles did not differ significantly (p < 0.05): 50 nm (2.9 ± 0.6 mm/min); 100 nm (3.8 ± 0.9 mm/min); 1000 nm (3.8 ± 0.8 mm/min); 6000 nm (3.2 ± 0.6 mm/min). In clear contrast, particles prepared from different PLGA-based copolymers (polylactic-co-glycolic acid) showed a significant effect on particle transport. PEG-PLGA particles (polyethylene glycol) showed the fastest and normal transport rates (5.9 ± 1.7 mm/min) compared to the ICRP's (International Commission of Radiological Protection) standard value for average tracheal transport rates (5.5 mm/min). Mucoadhesive chitosan-PLGA particles were transported at the slowest rate (0.7 ± 0.3 mm/min) of all particles tested. Overall, particle size and zeta-potential seem to be relatively uncritical, whereas material properties and the related particle surface chemistry significantly influence mucociliary particle clearance. Considering these findings in future drug formulation seems to be a promising strategy to improve inhalation therapy by prolonged particle/drug residence time within the airways.

Original languageEnglish (US)
Pages (from-to)233-241
Number of pages9
JournalJournal of Aerosol Medicine and Pulmonary Drug Delivery
Volume23
Issue number4
DOIs
StatePublished - Aug 1 2010
Externally publishedYes

Fingerprint

Mucociliary Clearance
Particle Size
Respiratory Therapy
Drug Compounding
Polystyrenes
Chitosan
Trachea
Pharmaceutical Preparations
polylactic acid-polyglycolic acid copolymer

Keywords

  • airways
  • inhalation therapy
  • Mucociliary clearance
  • nanoparticles, mucus

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Pharmacology (medical)
  • Pharmaceutical Science

Cite this

Influence of particle size and material properties on mucociliary clearance from the airways. / Henning, Andreas; Schneider, Marc; Nafee, Noha; Muijs, Leon; Rytting, Erik; Wang, Xiaoying; Kissel, Thomas; Grafahrend, Dirk; Klee, Doris; Lehr, Claus Michael.

In: Journal of Aerosol Medicine and Pulmonary Drug Delivery, Vol. 23, No. 4, 01.08.2010, p. 233-241.

Research output: Contribution to journalArticle

Henning, A, Schneider, M, Nafee, N, Muijs, L, Rytting, E, Wang, X, Kissel, T, Grafahrend, D, Klee, D & Lehr, CM 2010, 'Influence of particle size and material properties on mucociliary clearance from the airways', Journal of Aerosol Medicine and Pulmonary Drug Delivery, vol. 23, no. 4, pp. 233-241. https://doi.org/10.1089/jamp.2009.0806
Henning, Andreas ; Schneider, Marc ; Nafee, Noha ; Muijs, Leon ; Rytting, Erik ; Wang, Xiaoying ; Kissel, Thomas ; Grafahrend, Dirk ; Klee, Doris ; Lehr, Claus Michael. / Influence of particle size and material properties on mucociliary clearance from the airways. In: Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2010 ; Vol. 23, No. 4. pp. 233-241.
@article{6cbfc032f9ad4a5092f79f480261aff2,
title = "Influence of particle size and material properties on mucociliary clearance from the airways",
abstract = "Mucociliary clearance (MC), designed by evolution to eliminate inhaled and possibly noxious material from the airways, considerably limits the benefit of inhalation therapy. Although the principles of MC seem to be understood, there are still many open questions on mucociliary particle clearance. In this study a trachea-based in vitro model was used to investigate the effect of particle size, zeta-potential, and mucoadhesive particle properties on mucociliary particle clearance. As different sized particles (50-6000 nm) were tested at equal mass concentrations, size related factors, namely particle number and particle surface area, varied by several orders of magnitude between the experiments. Surprisingly, particle clearance for 50 nm up to 6000 nm-sized polystyrene particles did not differ significantly (p < 0.05): 50 nm (2.9 ± 0.6 mm/min); 100 nm (3.8 ± 0.9 mm/min); 1000 nm (3.8 ± 0.8 mm/min); 6000 nm (3.2 ± 0.6 mm/min). In clear contrast, particles prepared from different PLGA-based copolymers (polylactic-co-glycolic acid) showed a significant effect on particle transport. PEG-PLGA particles (polyethylene glycol) showed the fastest and normal transport rates (5.9 ± 1.7 mm/min) compared to the ICRP's (International Commission of Radiological Protection) standard value for average tracheal transport rates (5.5 mm/min). Mucoadhesive chitosan-PLGA particles were transported at the slowest rate (0.7 ± 0.3 mm/min) of all particles tested. Overall, particle size and zeta-potential seem to be relatively uncritical, whereas material properties and the related particle surface chemistry significantly influence mucociliary particle clearance. Considering these findings in future drug formulation seems to be a promising strategy to improve inhalation therapy by prolonged particle/drug residence time within the airways.",
keywords = "airways, inhalation therapy, Mucociliary clearance, nanoparticles, mucus",
author = "Andreas Henning and Marc Schneider and Noha Nafee and Leon Muijs and Erik Rytting and Xiaoying Wang and Thomas Kissel and Dirk Grafahrend and Doris Klee and Lehr, {Claus Michael}",
year = "2010",
month = "8",
day = "1",
doi = "10.1089/jamp.2009.0806",
language = "English (US)",
volume = "23",
pages = "233--241",
journal = "Journal of Aerosol Medicine and Pulmonary Drug Delivery",
issn = "1941-2711",
publisher = "Mary Ann Liebert Inc.",
number = "4",

}

TY - JOUR

T1 - Influence of particle size and material properties on mucociliary clearance from the airways

AU - Henning, Andreas

AU - Schneider, Marc

AU - Nafee, Noha

AU - Muijs, Leon

AU - Rytting, Erik

AU - Wang, Xiaoying

AU - Kissel, Thomas

AU - Grafahrend, Dirk

AU - Klee, Doris

AU - Lehr, Claus Michael

PY - 2010/8/1

Y1 - 2010/8/1

N2 - Mucociliary clearance (MC), designed by evolution to eliminate inhaled and possibly noxious material from the airways, considerably limits the benefit of inhalation therapy. Although the principles of MC seem to be understood, there are still many open questions on mucociliary particle clearance. In this study a trachea-based in vitro model was used to investigate the effect of particle size, zeta-potential, and mucoadhesive particle properties on mucociliary particle clearance. As different sized particles (50-6000 nm) were tested at equal mass concentrations, size related factors, namely particle number and particle surface area, varied by several orders of magnitude between the experiments. Surprisingly, particle clearance for 50 nm up to 6000 nm-sized polystyrene particles did not differ significantly (p < 0.05): 50 nm (2.9 ± 0.6 mm/min); 100 nm (3.8 ± 0.9 mm/min); 1000 nm (3.8 ± 0.8 mm/min); 6000 nm (3.2 ± 0.6 mm/min). In clear contrast, particles prepared from different PLGA-based copolymers (polylactic-co-glycolic acid) showed a significant effect on particle transport. PEG-PLGA particles (polyethylene glycol) showed the fastest and normal transport rates (5.9 ± 1.7 mm/min) compared to the ICRP's (International Commission of Radiological Protection) standard value for average tracheal transport rates (5.5 mm/min). Mucoadhesive chitosan-PLGA particles were transported at the slowest rate (0.7 ± 0.3 mm/min) of all particles tested. Overall, particle size and zeta-potential seem to be relatively uncritical, whereas material properties and the related particle surface chemistry significantly influence mucociliary particle clearance. Considering these findings in future drug formulation seems to be a promising strategy to improve inhalation therapy by prolonged particle/drug residence time within the airways.

AB - Mucociliary clearance (MC), designed by evolution to eliminate inhaled and possibly noxious material from the airways, considerably limits the benefit of inhalation therapy. Although the principles of MC seem to be understood, there are still many open questions on mucociliary particle clearance. In this study a trachea-based in vitro model was used to investigate the effect of particle size, zeta-potential, and mucoadhesive particle properties on mucociliary particle clearance. As different sized particles (50-6000 nm) were tested at equal mass concentrations, size related factors, namely particle number and particle surface area, varied by several orders of magnitude between the experiments. Surprisingly, particle clearance for 50 nm up to 6000 nm-sized polystyrene particles did not differ significantly (p < 0.05): 50 nm (2.9 ± 0.6 mm/min); 100 nm (3.8 ± 0.9 mm/min); 1000 nm (3.8 ± 0.8 mm/min); 6000 nm (3.2 ± 0.6 mm/min). In clear contrast, particles prepared from different PLGA-based copolymers (polylactic-co-glycolic acid) showed a significant effect on particle transport. PEG-PLGA particles (polyethylene glycol) showed the fastest and normal transport rates (5.9 ± 1.7 mm/min) compared to the ICRP's (International Commission of Radiological Protection) standard value for average tracheal transport rates (5.5 mm/min). Mucoadhesive chitosan-PLGA particles were transported at the slowest rate (0.7 ± 0.3 mm/min) of all particles tested. Overall, particle size and zeta-potential seem to be relatively uncritical, whereas material properties and the related particle surface chemistry significantly influence mucociliary particle clearance. Considering these findings in future drug formulation seems to be a promising strategy to improve inhalation therapy by prolonged particle/drug residence time within the airways.

KW - airways

KW - inhalation therapy

KW - Mucociliary clearance

KW - nanoparticles, mucus

UR - http://www.scopus.com/inward/record.url?scp=77955437973&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955437973&partnerID=8YFLogxK

U2 - 10.1089/jamp.2009.0806

DO - 10.1089/jamp.2009.0806

M3 - Article

VL - 23

SP - 233

EP - 241

JO - Journal of Aerosol Medicine and Pulmonary Drug Delivery

JF - Journal of Aerosol Medicine and Pulmonary Drug Delivery

SN - 1941-2711

IS - 4

ER -